Immatics N.V.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
/ 
Frequently asked questions
To buy Immatics N.V. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Immatics N.V. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Immatics N.V. is IMTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Immatics N.V. has its primary listing on NASDAQ (Small cap). You can trade Immatics N.V. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Immatics N.V. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Immatics N.V. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Immatics N.V..